Maximizing the safety profile of a novel cancer therapeutic via the DE-immunization of an engineered mammalian asparaginase
Ended Project Grant Awarded Last action
- Award ID
- R43CA243759
- Recipient
-
Enzyme By Design Inc. UEI CKUTZNUHGRN7
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $449,938
Award facts
- Assistance listing
- 93.396 Cancer Biology Research
- Completion date
- Place of performance
- Illinois, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $149,999 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Original award | $299,939 |
Quick answers
Who received award R43CA243759?
R43CA243759 was awarded to Enzyme By Design Inc. by National Cancer Institute (National Institutes of Health) on July 5, 2019.
How much is award R43CA243759 worth?
$449,938 has been obligated on R43CA243759.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award